NCT00842556View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Dapagliflozin

Tablets, Oral, 20 mg, Single Dose

DRUG

Glimepiride

Tablets, Oral, 4 mg, Single Dose

DRUG

Sitagliptin

Tablets, Oral, 100 mg, Single Dose

Trial Locations (1)

78744

Ppd Development, Austin

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AstraZeneca

INDUSTRY